HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): Cost comparison of two methods

Diagnostic Cytopathology

Volumn 33, Issue 2, 2005, Pages 138-143

  Layfield, Lester J ^a,d   Qureshi, M Nasar ^b,c  

^a ARUP LABORATORIES   (United States)

^b Lakewood Pathology Associates   (United States)

^c Bayonne Medical Center   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cytology; HPV triage; Human papillomavirus; Hybrid capture II; In situ hybridization; INFORM HPV

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; COLPOSCOPY; DEVICE; DIAGNOSTIC ACCURACY; DNA DETERMINATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REIMBURSEMENT; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL; STATISTICAL ANALYSIS; UNIVERSITY HOSPITAL; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; WART VIRUS;

ADOLESCENT; ADULT; AGED; COLPOSCOPY; COSTS AND COST ANALYSIS; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL DYSPLASIA;

EID: 23044432872     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.20316     Document Type: Article

References (17)

1. Nuovo GJ, Walsh LL, Gentile JL, Blanco JS, Koulos J, Heimann A. Correlation of the Papanicolaou smear and human papillomavirus type in women with biopsy-proven cervical squamous intraepithelial lesions. Am J Clin Pathol 1991;96:544-548.
2. Bosch FX, Manos MM, Munoz N. et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
3. Shiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province in Costa Rica. JAMA 2000;283:87-93.
4. Wright TC, Denny L, Kuhn L, Pollack A, Lorinez A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000;283:81-86.
5. Chan PK, Mak KH, Cheung JLK. Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong. J Med Virol 2002;68:273-275.
6. Franco EL, Rohan TE, Villa LL. Epidemiology evidence in human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 1999;91:506-511.
7. Walboomers JM, Jacobs MV, Manos MM. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
8. Schlecht NF, Kulaga S, Robitaille J. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106-3114.
9. Stoler MH. New Bethesda terminology and evidence-based management guidelines for cervical cytology findings. JAMA 2002;287: 1-7.
10. Wright TC, Cox JT, Massad LS. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2000;287:2120-2129.
11. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2001;287:2382-2390.
12. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000;92:397-402.
13. Solomon D, Schiffman M, Tarone R. ALTS Study Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299.
14. Wright TC, San YW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995;85:202-210.
15. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-2390.
16. Qureshi MN, Rudelli RD, Tubbs RR, Biscotti CV, Layfield LJ. The role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV. Diagn Cytopathol 2003;29:149-155.
17. Bolick DR. Laboratory implementation of human papillomavirus testing. Arch Pathol Lab Med 2003;127:984-990.